The team of Prof. Jiang Yuxin and Prof. Yang Meng from the Department of Diagnostic Ultrasound, PUMCH, in collaboration with Prof. Wang Qian, Prof. Li Mengtao and Prof. Zeng Xiaofeng from the Department of Rheumatology, carried out the first cohort study globa...

On May 26, the PUMCH prospective intervention study of osteoporotic re-fractures (Sequential Therapy with Teriparatide and Denosumab, STAND study) enrolled the first patient, marking essential strides in a major project led by Xia Weibo, Director of the Depart...

Recently, the PUMCH ophthalmology team led by Professor Zhang Meifen published an original article titled “Cerebrospinal Fluid Interleukin-10 Biomarker for Vitreoretinal Lymphoma” in the “American Journal of Ophthalmology” (Q1, ranked among top 5% journals acc...

On June 2, the phase I/II clinical trial of GC301 adeno-associated virus (AAV) injection (“GC301 injection”), a gene therapy drug for infantile-onset Pompe disease, were launched at Peking Union Medical College Hospital (PUMCH). GC301 injection, the China-deve...